Cargando…
Epstein–Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function
Epstein–Barr virus (EBV) expression was investigated by immunohistochemistry (latent membrane protein 1 [LMP-1]) and in situ hybridization (EBV encoded RNA [EBER]) in biopsies from 95 patients with untreated Hodgkin’s disease (HD). Tumour EBV status was related to EBV antibody titres, spontaneous an...
Autores principales: | Axdorph, U, Porwit-MacDonald, A, Sjöberg, J, Grimfors, G, Ekman, M, Wang, W, Biberfeld, P, Björkholm, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374328/ https://www.ncbi.nlm.nih.gov/pubmed/10584880 http://dx.doi.org/10.1038/sj.bjc.6690827 |
Ejemplares similares
-
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004) -
Effect of material deprivation on Epstein–Barr virus infection in Hodgkin's disease in the West Midlands
por: Flavell, K, et al.
Publicado: (1999) -
Assessment of the prognostic impact of the Epstein–Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease
por: Glavina-Durdov, M, et al.
Publicado: (2001) -
South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease
por: Flavell, K J, et al.
Publicado: (2001) -
Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents
por: Alexander, F E, et al.
Publicado: (2000)